Ying-Ze Zheng1, Lei Liang2. 1. Department of Obstetrics, Daqing People's Hospital, Daqing 163000, China. 2. Department of Obstetrics, Daqing People's Hospital, Daqing 163000, China. Electronic address: Lianglei-dq@163.com.
Abstract
BACKGROUND: Peroxidasin (PXDN) is an extracellular matrix protein with peroxidase activity. PXDN has been reported to participate in the processes of epithelial mesenchymal transition. However, the roles of PXDN in progression of cancers are still rare. METHODS: Expression profiles of PXDN in ovarian cancer (OC) tissues were obtained from GEO and TCGA database. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to measure the expression of PXDN in OC cells. Kaplan-Meier method was used to analyze the overall survival of OC patients. Furthermore, effects of PXDN knockdown on the proliferation, invasion as well as migration of HEY cells were examined by Cell Counting kit-8 (CCK-8), wound healing and transwell assay. Additionally, western blot assay was conducted to detect the levels of several key proteins in PI3K/Akt pathway. RESULTS: PXDN was highly expressed in OC tissues and cells. OC Patients with high PXDN expression showed poorer overall survival rate compared to the OC patients with low PXDN expression. The results of the present study demonstrated that knockdown of PXDN significantly suppressed the proliferation, invasion and migration of HEY cells. In addition, after silencing PXDN in HEY cells, the expression levels of the key protein phosphorylation in PI3K/Akt pathway were obviously decreased, including p-PI3K and p-Akt, that resulting in the inhibition of PI3K/Akt pathway activation. CONCLUSION: PXDN might play a promoter role in the proliferation, invasion and migration of OC cells through regulating the activation of PI3K/Akt pathway. Therefore, PXDN might be regarded as a potential target for OC therapy.
BACKGROUND:Peroxidasin (PXDN) is an extracellular matrix protein with peroxidase activity. PXDN has been reported to participate in the processes of epithelial mesenchymal transition. However, the roles of PXDN in progression of cancers are still rare. METHODS: Expression profiles of PXDN in ovarian cancer (OC) tissues were obtained from GEO and TCGA database. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to measure the expression of PXDN in OC cells. Kaplan-Meier method was used to analyze the overall survival of OC patients. Furthermore, effects of PXDN knockdown on the proliferation, invasion as well as migration of HEY cells were examined by Cell Counting kit-8 (CCK-8), wound healing and transwell assay. Additionally, western blot assay was conducted to detect the levels of several key proteins in PI3K/Akt pathway. RESULTS:PXDN was highly expressed in OC tissues and cells. OC Patients with high PXDN expression showed poorer overall survival rate compared to the OC patients with low PXDN expression. The results of the present study demonstrated that knockdown of PXDN significantly suppressed the proliferation, invasion and migration of HEY cells. In addition, after silencing PXDN in HEY cells, the expression levels of the key protein phosphorylation in PI3K/Akt pathway were obviously decreased, including p-PI3K and p-Akt, that resulting in the inhibition of PI3K/Akt pathway activation. CONCLUSION:PXDN might play a promoter role in the proliferation, invasion and migration of OC cells through regulating the activation of PI3K/Akt pathway. Therefore, PXDN might be regarded as a potential target for OC therapy.
Authors: Veronika F S Pape; Hajnal A Kovács; István Szatmári; Imre Ugrai; Bence Szikora; Imre Kacskovics; Zoltán May; Norbert Szoboszlai; Gábor Sirokmány; Miklós Geiszt Journal: Redox Biol Date: 2022-06-30 Impact factor: 10.787
Authors: Boushra Bathish; Martina Paumann-Page; Louise N Paton; Anthony J Kettle; Christine C Winterbourn Journal: J Biol Chem Date: 2020-07-16 Impact factor: 5.157
Authors: María J Arranz; Cristina Gallego-Fabrega; Ana Martín-Blanco; Joaquim Soler; Matilde Elices; Elisabet Dominguez-Clavé; Juliana Salazar; Daniel Vega; Laia Briones-Buixassa; Juan Carlos Pascual Journal: Transl Psychiatry Date: 2021-01-05 Impact factor: 6.222
Authors: Alessia Gagliardi; Vanessa L Porter; Zusheng Zong; Reanne Bowlby; Emma Titmuss; Constance Namirembe; Nicholas B Griner; Hilary Petrello; Jay Bowen; Simon K Chan; Luka Culibrk; Teresa M Darragh; Mark H Stoler; Thomas C Wright; Patee Gesuwan; Maureen A Dyer; Yussanne Ma; Karen L Mungall; Steven J M Jones; Carolyn Nakisige; Karen Novik; Jackson Orem; Martin Origa; Julie M Gastier-Foster; Robert Yarchoan; Corey Casper; Gordon B Mills; Janet S Rader; Akinyemi I Ojesina; Daniela S Gerhard; Andrew J Mungall; Marco A Marra Journal: Nat Genet Date: 2020-08-03 Impact factor: 38.330